La vendita allo scoperto per Cal-Maine Foods dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Cal-Maine Foods. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Cal-Maine Foods (NASDAQ:CALM) Azioni, Report sulle vendite allo scoperto

Cal-Maine Foods

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

Cal-Maine Foods Inc

Calmare Therapeutics Inc

Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) today announced that it has completed a strategic investment with Crepini LLC, establishing a new egg products and prepared foods joint venture. Crepini LLC, founded in 2007, has grown its brand throughout the United States and Mexico featuring egg wraps, protein pancakes, crepes, and wrap-ups, which are now sold online and in over 3,500 retail stores.
The new entity, located in Hopewell Junction, New York, will operate as Crepini Foods LLC ("Crepini"). Cal-Maine Foods will capitalize Crepini with approximately $6.75 million in cash to purchase additional equipment and other assets and fund working capital in exchange for a 51% interest in the new venture. Crepini LLC will contribute its existing assets and business in exchange for a 49% interest in the new venture.

News

Contracts

CALM

Cal-Maine Foods Has Completed A Strategic Investment With Crepini, Establishing A New Egg Products And Prepared Foods Joint Venture; The New Entity, Will Operate As Crepini Foods. Cal-Maine Foods Will Capitalize Crepini With ~$6.75M In Cash To Purchase Additional Equipment And Other Assets And Fund Working Capital In Exchange For A 51% Interest In The New Venture

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported quarterly earnings of $2.32 per share which beat the analyst consensus estimate of $1.85 by 25.41 percent. The company reported quarterly sales of $640.80 million which beat the analyst consensus estimate of $608.66 million by 5.28 percent. This is a 6.95 percent decrease over sales of $688.68 million the same period last year.

Earnings

Earnings Beats

Cal-Maine Foods Q4 2024 Adj EPS $2.32 Beats $1.85 Estimate, Sales $640.80M Beat $608.66M Estimate

Goldman Sachs analyst Adam Samuelson maintains Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) with a Sell and raises the price target from $47 to $52.

Price Target

Analyst Ratings

Goldman Sachs Maintains Sell on Cal-Maine Foods, Raises Price Target to $52

U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Wednesday.
Shares of U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) shares rose during Wednesday's session following a <a href="https://www.benzinga.com/news/earnings/24/07/39813946/us-bancorp-q2-earnings-net-interest-income-dips-but-fee-income-grows">second-quarter earnings beat</a>.
Revenue stood at $6.867 billion (-4.3% Y/Y), beating the consensus of $6.795 billion. Adjusted earnings per share totaled 98 cents, beating the consensus of 94 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
U.S. Bancorp shares gained 4.7% to $45.34 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) shares jumped 16.4% to $19.60 after the company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates. Also, the company announced it entered into a stock purchase agreement and made $12.7 million in orders for its FOX WaferPak full wafer Contractors.</li>
<li>The Honest Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) shares rose 14% to $4.0350.</li>
<li>GLOBALFOUNDRIES Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) surged 12.7% to $61.36.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) rose 11.1% to $11.11.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) gained 9.4% to $16.50 after the company announced a strategic partnership with CoreWeave.</li>
<li>fuboTV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) gained 9.1% to $1.5610</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) shares climbed 8.4% to $54.92 following a report suggesting the company is exploring a sale.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) rose 8.2% to $9.14.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) gained 8% to $16.27 after the company announced a strategic partnership with CoreWeave.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) rose 7.8% to $15.35 after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica for $1.5 billion in cash.</li>
<li>Nicolet Bankshares, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIC#NYSE">NIC</a>) surged 7.4% to $100.14 following upbeat quarterly earnings.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: CALM) shares rose 5.6% to $67.93. Cal-Maine Foods is scheduled to release its fourth quarter and fiscal 2024 financial results on Tuesday, July 23.</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) gained 5.5% to $1.0262.</li>
<li>Hancock Whitney Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) rose 5.3% to $56.51 following upbeat second-quarter results.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) gained 5.2% to $43.40.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39814468/alphabet-crowdstrike-and-2-other-stocks-insiders-are-selling">Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

AEHR

FUBO

GTLB

HNST

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SDST

US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday

Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) (&quot;Cal-Maine Foods&quot; or the &quot;Company&quot;) today announced the Company has completed the acquisition of substantially all the assets of ISE America, Inc. and certain affiliates (&quot;ISE&quot;) for approximately&nbsp;$110 million. Cal-Maine Foods is funding the acquisition with available cash on hand. The acquired ISE assets include commercial shell egg production and processing facilities with current capacity of approximately 4.7 million laying hens, including 1.0 million cage-free, and 1.2 million pullets, feed mills, approximately 4,000 acres of land, inventories and an egg products breaking facility. The acquired assets also include an extensive customer distribution network across the Northeast and Mid-Atlantic states, and production operations in Maryland, New Jersey, Delaware and South Carolina.

Cal-Maine Foods Acquires ISE America Assets for $110M, Expands Production Capacity

For consumers already dealing with sticky inflation, one food staple is unlikely to provide relief for a uniquely concerning reason.
At the end of April, egg prices increased by 16% since January due to a spike in bird flu among chickens, impacting facilities at Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>).
Over the past three years, nearly 91 million birds have tested positive for bird flu. Adding to this concern, less than two months ago, scientists confirmed bird flu could also be found in cattle.&nbsp;
Don't Miss:
<ul>
<li>A<a href="https://www.benzinga.com/money/overplay"> startup that turns videos into games gets backing from Mark Cuban</a> and opens a round for regular investors at $250.</li>
<li>Elon Musk and Jeff Bezos are bullish on one city that could dethrone New York and become the new financial capital of the US.<a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital"> Investing in its booming real estate market has never been more accessible</a>.</li>
</ul>
Dr. Lars Larsen, a veterinary microbiologist at the University of Copenhagen, explained the significance of the findings: "We see an enormous amount of virus in the mammary glands and in the milk" compared to other mammals.
Even more concerning, scientists recently confirmed that cows have human flu receptors, which could act as a "mixing vessel" for different virus mutations.
A co-study by scientists at the University of Copenhagen and St. Jude Children's Research Hospital in Memphis wrote that "these results provide a mechanistic rationale for the high levels of H5N1 virus reported in infected bovine milk and show cattle have the potential to act as a mixing vessel for novel [influenza virus] generation."
Trending: Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —<a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"> How much is that worth today?</a>
While the CDC maintains that the "risk to the general public remains low" and that human-to-human transmission remains "rare," the spread in cattle has already affected humans, with 70 dairy farmworkers in Colorado currently undergoing monitoring for possible symptoms of bird flu.&nbsp;
The CDC&#8217;s concern about a potential outbreak of bird flu <a href="https://www.benzinga.com/general/24/04/38220057/bill-gates-called-for-a-universal-flu-vaccine-now-the-cdc-director-says-the-organization-is-activate">remains at the top of the mind</a>, but a core issue for the agency now is to get the public to listen to it.
While the CDC has strongly advised against consuming raw milk due to the increase of bird flu among cows, warning that "raw milk can be contaminated with harmful germs that can make you very sick," the sale of unpasteurized milk has not reduced.&nbsp;
According to market research firm NielsenIQ, sales of raw milk have increased between 21% and 65% since March 25, when bird flu was first confirmed in cattle.&nbsp;
Keep Reading:
<ul>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." These<a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail"> high-yield real estate notes that pay 7.5% &#8211; 9%</a> make earning passive income easier than ever.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich-advisor">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>

General

After 91 Million Birds Infected With Bird Flu In 3 Years, New Findings On Cows Raise Concerns: 70 Workers Monitored For Symptoms

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>Dividend Yield: 3.30%</li>
<li>Stephens &amp; Co. analyst Ben Beinvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 75%.</li>
<li>Goldman Sachs analyst Adam Samuelson maintained a Sell rating and increased the price target from $42 to $47 on March 12, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 4, Cal-Maine Foods said Jeff Hardin, Senior Vice President of Sales, is retiring from his position with the Company, effective July 23, 2024.</li>
</ul>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 9.01%</li>
<li>Stifel analyst Matthew Smithreiterated a Buy rating with a price target of $50 on March 25. This analyst has an accuracy rate of 64%.</li>
<li>Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating with a price target of $45 on July 18, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On April 25, Altria Group reported a first-quarter FY24 sales decline of 2.5% year-on-year to $5.58 billion, beating the analyst consensus estimate of $4.71 billion.</li>
</ul>
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 5.79%</li>
<li>UBS analyst Kevin Caliendomaintained a Neutral rating and cut the price target from $25 to $22 on April 3. This analyst has an accuracy rate of 74%.</li>
<li>Morgan Stanley analyst Erin Wright maintained an Underweight rating and lowered the price target from $21 to $20 on April 1. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On April 24, DoorDash and Walgreens announced a new collaboration to offer SNAP/EBT payment at nearly 7,800 Walgreens stores across the country.</li>
</ul>
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38663466/over-10m-bet-on-sensata-technologies-check-out-these-4-stocks-insiders-are-buying">Over $10M Bet On Sensata Technologies? Check Out These 4 Stocks Insiders Are Buying</a>

Dividends

Pre-Market Outlook

Wall Street's Most Accurate Analysts' Views On 3 Risk Off Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a &lt;a href=&#8221;https://www.benzinga.com/yield-investments&#8221;&gt;&lt;em&gt; high dividend payout. &lt;/em&gt;&lt;/a&gt;
Benzinga readers can review the latest analyst takes on their favorite stocks&amp;nbsp;by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga&#8217;s extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>Dividend Yield: 3.13%</li>
<li>Stephens &amp; Co. analyst Ben Beinvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 74%.</li>
<li>Goldman Sachs analyst Adam Samuelson maintained a Sell rating and raised the price target from $42 to $47 on March 12, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On April 4, Cal-Maine Foods said Jeff Hardin, Senior Vice President of Sales, is retiring from his position with the Company, effective July 23, 2024.</li>
</ul>
<h3 class="wp-block-heading">Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>)</h3>
<ul>
<li>Dividend Yield: 5.55%</li>
<li>Morgan Stanley analyst Pamela Kaufman maintained an Overweight rating and cut the price target from $118 to $113 on Oct. 2, 2023. This analyst has an accuracy rate of 65%.</li>
<li>Barclays analyst Gaurav Jain maintained an Overweight rating and slashed the price target from $115 to $100 on Sept. 21, 2023. This analyst has an accuracy rate of 74%.</li>
<li>Recent News: Philip Morris International is expected to report first-quarter earnings on April 23, 2024.</li>
</ul>
<h3 class="wp-block-heading">The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)</h3>
<ul>
<li>Dividend Yield: 4.23%</li>
<li>B of A Securities analyst Bryan Spillane maintained a Buy rating and raised the price target from $40 to $42 on April 15, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and cut the price target from $38 to $37 on Feb. 15, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Recent News: The Kraft Heinz Company is expected to release its first quarter 2024 financial results on May 1, 2024.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38351344/brown-brown-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-stre">Brown &amp; Brown Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a>

Wall Street's Most Accurate Analysts' Views On 3 Defensive Stocks Delivering High-Dividend Yields

Cal-Maine Foods Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) is the largest and leading producer and distributor of fresh shell eggs in the United States, with a 19% market share. Shareholders are rejoicing over its strong fiscal Q3 2024 earnings report and special $1.00 dividend. The company has staged a solid turnaround despite egg prices falling and the growing concerns over highly pathogenic avian influenza (HPAI).
Demand has remained stronger than ever, as reflected by its blockbuster earnings figures. Despite record volumes, the basic materials sector stock is still in value investing territory, with shares trading at just 11.15X earnings and 13.59X forward earnings. It competes with Post Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/post#NYSE">POST</a>) as one of the largest food service suppliers of egg products.
<h2>Avian Flu Impacts </h2>
Concerns over avian flu (h5n1) have been making headlines, with farm livestock and cattle getting infected and even human infections becoming a reality. The USDA reported nearly 15.7 million commercial layer hens and pullets were depopulated (terminated) between November 2023 and January 2024. Cal-Maine experienced an outbreak in its Kansas facility, resulting in 1.5 million laying hens and 240,000 pullets being depopulated.
On April 2, 2024, the company reported positive test results for avian flu at its Parmer County, Texas facility, resulting in depopulating 1.6 million egg-laying hens (adult female chickens) and 337,000 pullets (less than 1 year-old female chickens) or 3.6% of its total flock. Production at the facility has been temporarily halted.&nbsp;
Cal-Maine was impacted by the significant egg supply reduction. With recent outbreaks causing market prices to spike, the overall impact is still considered to not be severe according to the company.
<h2>Growing Portfolio of Brands</h2>
The company has continued to acquire farms like Fassio Egg Farms and a closed broiler processing plant, hatchery and feed mill from Tyson Foods Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsn#NYSE">TSN</a>) to help meet the strong demand. While you may not have seen Cal-Maine namesake brand eggs at your local grocer, you&#39;ve more than likely purchased eggs under their portfolio of brands. They include Farmhouse, 4-Grain, Egg-Land&#39;s Best, Sunny Meadows and Land O&#39;Lakes.
<img alt="calm stock daily cup and handle breakout" src="https://www.marketbeat.com/logos/articles/med_20240407134930_chartz-calm.jpg" style="height:800px; width:915px" />
<h2>Daily Cup and Handle Breakout </h2>
The daily candlestick chart on CALM illustrates a cup and handle breakout pattern. The cup lip line formed on the double top at $58.31 on April 4, 2023. Shares sold off to a swing low of $42.16 on October 4, 2023, before staging a rally back towards the cup lip line, peaking at $57.83. CALM pulled back down to $52.91 on January 4, 2024, to set the stage for the handle formation as shares attempted twice to break the cup lip line, eventually reaching a new high peak at $64.76. The daily relative strength index (RSI) is testing the 70-band on its recent bounce. Pullback support levels are at $58.31, $55.11, $50.23 and $48.06.
<h2>Eggs-Citing EPS Beat and Special Dividend &nbsp;</h2>
On April 2, 2024, Cal-Maine reported an EPS of $3.00, beating consensus estimates for $2.45 by 55 cents. Revenues fell 29.5% YoY to $703.08 million, beating $692.35 million consensus estimates. The company will pay out a special $1.00 dividend to hold its Class A common stock, payable May 16, 2024, to holders of record as of May 1, 2024.
<h2>CEO Insights </h2>
Cal-Maine CEO Max Bowman noted that its fiscal Q3 2024 sales of $703.1 million were up against tough comps of $997.5 million in the year-ago period, which was the company&#39;s highest quarterly sales period with record high average selling prices for specialty and conventional eggs. The sales decline was a result of a significant drop in supplies due to the avian flu. Market prices have spiked as a result. Overall volume rose 3.2% to 300.9 million dozen.
Conventional eggs sold grew 2.6% to 192.2 million dozen, while specialty eggs rose 4.4% YoY to 108.6 million dozen sold. The net average selling price per dozen conventional eggs dropped 40% to $2.152 compared to $3.678 in the year-ago period. Specialty egg prices fell from $2.616 per dozen, down 36.1%, to $2.415 per dozen.
Bowman commented, &quot;Demand for shell eggs has remained strong as consumers look for an affordable and nutritious protein option. Across our operations, we are focused on meeting this demand as we continue to identify opportunities to extend our market reach.&quot;
Bowman concluded, &quot;We have a strong balance sheet that provides us with the flexibility to fund our growth initiatives, including potential acquisitions. We believe fiscal 2024 will be another successful year for the Company, and we look forward to the opportunities ahead for Cal-Maine Foods.&quot;
<a href="https://www.marketbeat.com/stocks/NASDAQ/CALM/price-target/">Cal-Maine analyst ratings and price targets</a> are at MarketBeat. Cal-Maine&#39;s peers and competitor stocks can be found with the <a href="https://marketbeat.com/stock-screener/">MarketBeat stock screener.</a>
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/cal-maine-foods-delivers-an-eggs-citing-eps-beat/">Cal-Maine Foods Delivers an Eggs-Citing EPS Beat</a>&quot; first appeared on MarketBeat.

POST

Cal-Maine Foods Delivers an Eggs-Citing EPS Beat

Shares of Ulta Beauty, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulta#NASDAQ">ULTA</a>) fell sharply during Wednesday&rsquo;s session amid the company&#39;s presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook.
Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>ARCA biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abio#NASDAQ">ABIO</a>) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences.</li>
<li>Next Technology Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtt#NASDAQ">NXTT</a>) rose 57.4% to $6.42.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals&#39; Fanapt&reg; received U.S. FDA approval for the acute treatment of Bipolar I Disorder.</li>
<li>VivoPower International PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvpr#NASDAQ">VVPR</a>) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) gained 32.7% to $0.0345.</li>
<li>XTI Aerospace, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xtia#NASDAQ">XTIA</a>) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc.</li>
<li>Brooge Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brog#NASDAQ">BROG</a>) gained 28.8% to $3.0790.</li>
<li>Addex Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxn#NASDAQ">ADXN</a>) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.</li>
<li>Aesthetic Medical International Holdings Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aih#NASDAQ">AIH</a>) gained 24.3% to $0.3981 after gaining 13% on Tuesday.</li>
<li>LAMF Global Ventures Corp. I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvc#NASDAQ">LGVC</a>) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd.</li>
<li>Quhuo Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qh#NASDAQ">QH</a>) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023.</li>
<li>Destiny Tech100 Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NYSE">DXYZ</a>) gained 21.4% to $25.77.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) gained 20.5% to $5.40 following a massive rally to start the week. CXApp shares rallied more than 150% to start the week after the company announced a partnership with Alphabet&rsquo;s Google Cloud.</li>
<li>Clean Energy Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cety#NASDAQ">CETY</a>) climbed 20.5% to $1.63.</li>
<li>American Battery Technology Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abat#NASDAQ">ABAT</a>) rose 17.7% to $1.9301. American Battery Technology Company was awarded $20 million tax credit through competitive U.S. DOE process to advance its critical minerals battery recycling facility.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares rose 14.9% to $0.0470 after gaining 13% on Tuesday. On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.</li>
<li>Pyxis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyxs#NASDAQ">PYXS</a>) gained 12.3% to $6.04.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) surged 11.4% to $2.08. Maxim Group analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares rose 10.2% to $68.22 after the company reported fourth quarter results.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) jumped 9.7% to $3.16.</li>
<li>Signet Jewelers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sig#NYSE">SIG</a>) gained 9.2% to $103.80after the company raised its FY25 guidance.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) gained 9% to $0.0512. On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) gained 7.4% to $30.28.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) climbed 6.8% to $62.88 after the company reported upbeat results for its fourth quarter.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Casa Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/casa#NASDAQ">CASA</a>) shares dipped 78.1% to $0.0563 after the Company filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) fell 61.9% to $0.4196 after the company filed for Chapter 11 bankruptcy. The company on Tuesday said it reached a real with Cantor Fitzgerald and RXR to become a private company.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 44.5% to $0.0232 after the company announced pricing of a $1.5 million public offering of common stock.</li>
<li>GCT Semiconductor Holding, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gcts#NYSE">GCTS</a>) dipped 40% to $9.29 amid volatility following the company&#39;s recently completed business combination with Concord Acquisition Corp III and NYSE debut.</li>
<li>FibroGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fgen#NASDAQ">FGEN</a>) fell 32.8% to $1.4499. FibroGen announced topline data from the Fortis Therapeutics-sponsored Phase 1 study of FG-3246 (also known as FOR46), a potential first-in-class anti-CD46 antibody drug conjugate (ADC) with an MMAE-containing payload.</li>
<li>Keyarch Acquisition Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kych#NASDAQ">KYCH</a>) fell 28.5% to $9.65.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) dipped 24.2% to $0.3148 as the company issued an update on ongoing ENVASARC Phase 2 pivotal trial following Independent Data Monitoring Committee Recommendation to continue the trial as planned.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) fell 22.5% to $0.9741 after dipping around 12% on Tuesday.</li>
<li>Anghami Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angh#NASDAQ">ANGH</a>) fell 22.2% to $1.40. Anghami recently announced that it completed its transaction with OSN+.</li>
<li>Locafy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcfy#NASDAQ">LCFY</a>) dipped 21.9% to $3.67 following second-quarter results.</li>
<li>Vicinity Motor Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vev#NASDAQ">VEV</a>) fell 19.3% to $0.75 after the company reported a year-over-year decrease in fourth-quarter EPS results.</li>
<li>Enveric Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envb#NASDAQ">ENVB</a>) dipped 18.4% to $0.93.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) fell 16.8% to $10.39.</li>
<li>Critical Metals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) fell 16.7% to $11.66.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares fell 12% to $2.20. Acorda Therapeutics shares dipped 81% on Tuesday after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.</li>
<li>Exscientia plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exai#NASDAQ">EXAI</a>) fell 10.8% to $4.6395 following quarterly results.</li>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares fell 8.4% to $0.0403 after gaining 18% on Tuesday.</li>
<li>e.l.f. Beauty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elf#NYSE">ELF</a>) fell 8.2% to $170.71 after peer Ulta Beauty reportedly issued weak guidance at a conference.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) fell 8% to $7.21.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) shares tumbled 7.3% to $6.11 after gaining 8% on Tuesday.</li>
<li>Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) fell 6.1% to $3.5850.</li>
<li>Lands&#39; End, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/le#NASDAQ">LE</a>) fell 6.1% to $11.25.</li>
<li>Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) fell 6.1% to $41.27 after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38069445/ethereum-trades-below-3-400-following-adp-report-stacks-becomes-top-loser"> Ethereum Trades Below $3,400 Following ADP Report; Stacks Becomes Top Loser</a>

Penny Stocks

Small Cap

ABAT

ABIO

ACOR

ADXN

ANGH

APLD

ATAI

BCAN

BROG

CASA

CETY

CISS

CRML

CXAI

DXYZ

EGOX

ENVB

ESPR

EXAI

FGEN

GCTS

GMDA

INTC

Kintara Therapeutics, Inc. - Common Stock

KTRA

KYCH

LCFY

LGVC

MESO

MRNO

NWTN

Next Technology Holding Inc. - Ordinary Shares

NXTT

ONMD

PLAY

PYXS

SINT

SMTC

TCON

ULTA

VIEW

VNDA

VVPR

XTIA

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Shares of Signet Jewelers Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sig#NYSE">SIG</a>) rose sharply during Wednesday&rsquo;s session after the company <a href="https://www.benzinga.com/markets/equities/24/04/38068195/whats-going-on-with-signet-jewelers-stock-today">raised its FY25 guidance.</a>
The company and Leonard Green &amp; Partners, L.P., an equity investment firm, today announced the amendment of the terms of the Series A Convertible Preference Shares to net share settlement and the repurchase of half of the Preferred Shares. 
Signet increased its FY25 adjusted EPS outlook to $9.90 &ndash; $11.52 from $9.08 &ndash; $10.48 versus an estimate of $9.72.
Signet Jewelers shares surged 9.2% to $103.80 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Destiny Tech100 Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NYSE">DXYZ</a>) shares jumped 21.4% to $25.77.</li>
<li>Ocugen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) shares gained 14.2% to $1.5750. HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterated Ocugen with a Buy and maintained a $7 price target.</li>
<li>Pyxis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyxs#NASDAQ">PYXS</a>) rose 12.3% to $6.04.</li>
<li>Atai Life Sciences N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>) climbed 11.4% to $2.08. Maxim Group analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.</li>
<li>SolarMax Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) rose 10.4% to $11.85.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares gained 10.2% to $68.22 after the company reported fourth quarter results.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) gained 9.7% to $3.16.</li>
<li>TransMedics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmdx#NASDAQ">TMDX</a>) rose 9.2% to $79.47.</li>
<li>Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) gained 8.3% to $4.3450. Cantor Fitzgerald analyst Josh Siegler maintained Porch Group with an Overweight and raised the price target from $3 to $5.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) gained 7.7% to $10.95.</li>
<li>Semtech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtc#NASDAQ">SMTC</a>) climbed 7.4% to $30.28.</li>
<li>Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) shares gained 6.8% to $62.88 after the company reported upbeat results for its fourth quarter.</li>
<li>Glaukos Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gkos#NYSE">GKOS</a>) rose 6.8% to $95.59. Glaukos received permanent J-code for iDose&reg; TR (travoprost intracameral implant).</li>
<li>Blue Owl Capital Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/owl#NYSE">OWL</a>) gained 6.4% to $19.69 after the company announced a purchase agreement to acquire Kuvare Insurance Services LP for $750 million.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) rose 6.3% to $23.88.</li>
<li>U.S. Silica Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slca#NYSE">SLCA</a>) gained 6.2% to $13.47.</li>
<li>Spotify Technology S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>) rose 5.6% to $284.61 on reports the company will raise monthly prices.</li>
<li>Arcadium Lithium plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/altm#NASDAQ">ALTM</a>) gained 4.8% to $4.34. Raymond James upgraded the stock from Outperform to Strong Buy and maintained its $9 price target.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38062892/how-to-earn-500-a-month-from-levi-strauss-stock-ahead-of-q1-earnings-report"> How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q1 Earnings Report</a>

ALTM

GKOS

OCGN

PRCH

RILY

SLCA

SMXT

SPOT

TMDX

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday

Stephens &amp; Co. analyst Ben Bienvenu reiterates Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) with a Equal-Weight and maintains $65 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on Cal-Maine Foods, Maintains $65 Price Target

Shares of Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) rose sharply in today&rsquo;s pre-market trading after the company reported <a href="https://www.benzinga.com/news/earnings/24/04/38058699/cal-maine-foods-reports-better-than-expected-q3-results">upbeat results for its fourth quarter</a>.
The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Cal-Maine Foods shares jumped 8.3% to $63.80 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>LAMF Global Ventures Corp. I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvc#NASDAQ">LGVC</a>) rose 148.9% to $26.79 in pre-market trading. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd.</li>
<li>Aesthetic Medical International Holdings Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aih#NASDAQ">AIH</a>) gained 68.3% to $0.5389 in pre-market trading after gaining 13% on Tuesday.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) gained 34.1% to $1.06 in pre-market trading. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement of senior convertible notes.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) shares gained 28.1% to $5.01 in pre-market trading. Vanda Pharmaceuticals&#39; Fanapt&reg; received U.S. FDA approval for the acute treatment of Bipolar I Disorder.</li>
<li>Inspire Veterinary Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivp#NASDAQ">IVP</a>) gained 16% to $0.0545 in pre-market trading. On Jan. 5, Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares rose 15.6% to $0.0473 in pre-market trading after gaining 13% on Tuesday. On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) climbed 11.1% to $0.50 in pre-market trading after gaining around 3% on Tuesday.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) shares rose 9.2% to $0.3735 in pre-market trading. Edible Garden announced a reverse stock split of the company&#39;s common stock.</li>
<li>Dave &amp; Buster&#39;s Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/play#NASDAQ">PLAY</a>) shares rose 6.3% to $65.81 in pre-market trading after the company reported fourth quarter results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) declined 61.8% to $0.42 in pre-market trading after the company reached a real with Cantor Fitzgerald and RXR to become a private company.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares dropped 24% to $1.90 in pre-market trading. Acorda Therapeutics shares dipped 81% on Tuesday after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) fell 23.4% to $1.18 in pre-market trading after jumping 63% on Tuesday.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 22.5% to $0.0324 in pre-market trading after gaining 5% on Tuesday. SiNtx Technologies recently announced a proposed public offering of common stock.</li>
<li>VivoPower International PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvpr#NASDAQ">VVPR</a>) fell 18.4% to $4.80 pre-market trading. VivoPower shares jumped 304% on Tuesday after the company&#39;s Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) shares tumbled 13.1% to $5.73 in pre-market trading after gaining 8% on Tuesday.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) fell 11.1% to $1.12 pre-market trading after dipping around 12% on Tuesday.</li>
<li>Gamida Cell Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmda#NASDAQ">GMDA</a>) shares fell 10% to $0.0396 in pre-market trading after gaining 18% on Tuesday.</li>
<li>Fractyl Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/guts#NASDAQ">GUTS</a>) fell 9.1% to $6.13 in pre-market trading after declining around 10% on Tuesday. The company recently announced FDA IDE approval for the Revita Remain-1 pivotal study and then rebounded after reporting Q4 financial results.</li>
<li>Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) fell 4.8% to $41.85 in pre-market trading after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporting structure designed to drive increased cost discipline and higher returns by providing greater transparency, accountability and incentives across the business.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38062468/acuity-brands-likely-to-report-higher-q2-earnings-here-are-the-recent-forecast-changes-from-wall-st"> Acuity Brands Likely To Report Higher Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts</a>

EDBL

GUTS

MOTS

Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Gloom persists on Wall Street as stock futures point to a sluggish start on Wednesday, with the tech space potentially pressured by recent setbacks and&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38062166/taiwan-shaken-by-massive-7-2-magnitude-earthquake-forcing-tsmc-to-suspend-chip-production" rel="noreferrer noopener">the earthquake in Taiwan</a>, home to several tech industry suppliers. Traders also face key data on services and jobs, along with remarks from several&nbsp;Federal Reserve&nbsp;officials.
Cues From Previous Session:
Rate worries weighed heavily on Tuesday, pushing all major averages down by more than 2%. Tuesday&#8217;s data releases, including a rebound in manufacturing activity and in-line job openings, reinforced concerns about a strong economy that could prompt the Fed to raise interest rates more aggressively. The indices opened significantly lower and remained flat for most of the session, with the Dow Jones Industrial Average and the S&amp;P 500 ending lower for a second consecutive day.
The sell-off was broad-based, with consumer discretionary, healthcare, and real estate stocks leading the decline. Energy stocks, on the other hand, rallied strongly on continued oil price strength, while utility and communication services edged higher. 
The Dow and Nasdaq Composite closed at their lowest points in two weeks, reflecting broader market anxieties.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.95%</td>
<td>16,240.45</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>-0.72%</td>
<td>5,205.81</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>-1.00%</td>
<td>39,170.24</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.80%</td>
<td>2,065.04</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Notwithstanding the recent lean patch, a fund manager is optimistic about a near-term recovery. &#8220;Spring is a happy time of year.  This good feeling rubs off on the stock market since April is a seasonally strong month,&#8221; said fund Louis Navellier. Citing Bespoke data, he said the Dow Industrials has posted an average April gain of 2.2% in the past 50 years.  
Navellier also sees another reason to be optimistic. &#8220;The other reason that April is such a strong month is due to annual pension funding before taxes are filed,&#8221; he said.
Futures Today
 Futures Performance On Wednesday ( as of 7 a.m. EDT)
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.21%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.07%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.01%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.05%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> In <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noreferrer noopener">premarket</a>&nbsp;trading on Wednesday, the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) slipped 0.05% to $518.35,&nbsp;and the&nbsp;Invesco QQQ ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.23% to $440.11 according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.</figcaption></figure>
Upcoming Economic Data:
ADP is scheduled to release its March private payrolls report at 8:15 a.m. EDT. Economists, on average, expect, the private sector to have added 155,000 jobs compared to the 140,000 number for February.
S&amp;P Global will release its final service sector PMI for March at 9:45 a.m. EDT. The flash reading released last month came in at 51.7, down from 54.6 in February.
The ISM&#8217;s non-manufacturing PMI, due at 10 a.m. EDT, is widely expected to remain flattish at 52.7 for March.
The Energy Information Administration will release its customary weekly petroleum status report at 10:30 a.m. EDT.
Among the Fed speeches for the day are:
<ul>
<li>Fed Governor Michelle Bowman: 9:45 a.m. EDT</li>
<li>New York Fed President John Williams: noon EDT</li>
<li>Fed Chair Powell: 12:10 p.m. EDT</li>
<li>Fed Vice Chair for Supervisions Michael Barr: 1:10 p.m. EDT</li>
</ul>
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Stocks In Focus:
<ul>
<li>Dave &amp; Buster&#8217;s Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) rallied over 7% <a href="https://www.benzinga.com/premarket">in premarket trading </a>following its results announcement, and Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) jumped over 8%.</li>
<li>Acuity Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) slipped nearly 2% in reaction to its quarterly results.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>), Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>), and Resources Connection, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGP#NASDAQ">RGP</a>) are among the companies <a href="https://www.benzinga.com/calendars/earnings">due to release their quarterly earnings </a>on Wednesday.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) declined about 1% in the follow-through sell-off post-first-quarter deliveries report.</li>
<li>Chipmaker Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) fell over 4% after its foundry unit posted a nearly $7 billion operating loss in 2023</li>
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) also slipped after their foundry Taiwan Semiconductor Manufacturing Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) was forced to evacuate its factory following an earthquake in the country.</li>
</ul>
Commodities, Bonds, and Global Equity Markets:
Crude oil futures rallied yet again on Wednesday and were closing in on the $86-a-barrel mark, while gold futures continued their record run. The yield on the benchmark 10-year Treasury remained flattish after the surge on Tuesday.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was flatlining and traded shy of the $66,000 level.
In equity markets, Asian stocks fell across the board on souring rate-cut hopes, while the major European stocks traded mostly higher amid the release of some weak domestic economic data.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38047230/historic-s-p-500-rally-in-q1-flashes-bullish-signals-for-2024-only-the-ninth-time-s">Historic S&amp;P 500 Rally In Q1 Flashes Bullish Signals For 2024: &#8216;Only The Ninth Time Since 1940&#8217;</a>
Photo by Tada Images on Shutterstock

Equities

Futures

Previews

Economics

Federal Reserve

$BTC

LEVI

NVDA

TSLA

Wall Street Set To Stumble At Open As Traders Eye Key Data, Fed Chair Powell's Speech: Analyst Finds 2 Reasons To Stay Optimistic In April

WIIM

Cal-Maine Foods shares are trading higher after the company reported better-than-expected Q3 EPS and revenue.

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Acuity Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ayi#NYSE">AYI</a>) to report quarterly earnings at $3.25 per share on revenue of $907.75 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Acuity Brands shares fell 1.3% to close at $261.83 on Tuesday.
Cal-Maine Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calm#NASDAQ">CALM</a>) reported upbeat results for its fourth quarter. The company&nbsp;reported quarterly earnings of&nbsp;$3.00&nbsp;per share which beat the analyst consensus estimate of&nbsp;$2.46 per share. Cal-Maine Foods shares surged 7% to $63.05 in the after-hours trading session.
Analysts are expecting Levi Strauss &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/levi#NYSE">LEVI</a>) to have earned 21 cents per share on revenue of $1.55 billion. The company will release earnings after the markets close. Levi Strauss shares rose 0.3% to $18.80 in the after-hours trading session.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) shares fell sharply during Tuesday&rsquo;s after-hours trading after the company reached a real with Cantor Fitzgerald and RXR to become a private company. View shares tumbled 53.7% to $0.5099 in the after-hours trading session.
Analysts expect BlackBerry Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) to post a quarterly loss at 3 cents per share on revenue of $154.78 million after the closing bell. BlackBerry shares slipped 0.01% to $2.7997 in after-hours trading.
&nbsp;
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38039647/jim-cramer-says-ka-ching-for-this-airline-stock-plus-ring-the-register-for-kodiak"> Jim Cramer Says &#39;Ka-Ching&#39; For This Airline Stock, Plus: &#39;Ring The Register&#39; For Kodiak </a>

Acuity Brands, Cal-Maine Foods And 3 Stocks To Watch Heading Into Wednesday

Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported its fourth-quarter financial results after the bell Tuesday. Here's a <a href="https://www.benzinga.com/pressreleases/24/04/b38056887/cal-maine-foods-reports-results-for-third-quarter-fiscal-2024">look at the highlights.&nbsp;</a>
The Details: Cal-Maine Foods reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 by 21.95%. 
Quarterly sales clocked in at $703.08 million which beat the analyst consensus estimate of $692.35 million by 1.55% and represents a 29.52% decrease over sales of $997.49 million from the same period last year.
The company also reported that one of its facilities in Palmer County, Texas, tested positive for highly pathogenic avian influenza (HPAI), resulting in depopulation of approximately 1.6 million laying hens and 337,000 pullets, or approximately 3.6% of its total flock as of March 2. 
Production at the facility has temporarily ceased as the company follows the protocols prescribed by the USDA. 
Cal-Maine Foods said it is working to secure production from other facilities to minimize disruption to its customers.
&#8220;We are very pleased with Cal-Maine Foods&#8217; strong financial and operating performance for the third quarter of fiscal 2024. Our sales reflect lower average selling prices compared to a year ago, when the shell egg industry experienced record high market prices due primarily to the impact of highly pathogenic avian influenza (HPAI) and other market factors resulting in a significant reduction in supply,&#8221; commented Sherman Miller, CEO of Cal-Maine Foods. 
&#8220;While the more recent outbreaks of HPAI have also affected supply and caused market prices to move higher, the overall market impact has not been as severe. Fueled by strong demand, our total sales volumes (dozens sold) for the quarter were higher than the third quarter of fiscal 2023 and reached a Company record,&#8221; added Miller. 
Related News: <a href="https://www.benzinga.com/news/24/04/38029934/whats-going-on-with-amc-entertainment-stock">What&#8217;s Going On With AMC Entertainment Stock?</a>
CALM Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Cal-Maine Foods shares are up 6.04% after-hours at $62.47 at the time of publication Tuesday.
Photo: Monika from Pixabay

After-Hours Center

Cal-Maine Foods Reports Better-Than-Expected Q3 Results

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported its Q3 earnings results on Tuesday, April 2, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Cal-Maine Foods beat estimated earnings by 22.0%, reporting an EPS of $3.0 versus an estimate of $2.46.
Revenue was down $294.42 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.18 which was followed by a 3.0% increase in the share price the next day.
Here's a look at Cal-Maine Foods's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.83</td>
<td>0.25</td>
<td>2.15</td>
<td>5.47</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.65</td>
<td>0.02</td>
<td>2.27</td>
<td>6.62</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>525.39M</td>
<td>473.37M</td>
<td>605.43M</td>
<td>888.21M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>523.23M</td>
<td>459.34M</td>
<td>688.68M</td>
<td>997.49M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Cal-Maine Foods <a href="https://www.benzinga.com/quote/CALM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Cal-Maine Foods Q3 Earnings

Cal-Maine Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) ("Cal-Maine Foods" or "Company") today reported that one of the Company's facilities located in Parmer County, Texas, tested positive for highly pathogenic avian influenza ("HPAI"), resulting in depopulation of approximately 1.6 million laying hens and 337,000 pullets, or approximately 3.6% of the Company's total flock as of March 2, 2024. Production at the facility has temporarily ceased as the Company follows the protocols prescribed by the USDA. Cal-Maine Foods is working to secure production from other facilities to minimize disruption to its customers.
The Company remains dedicated to robust biosecurity programs across its locations; however, no farm is immune from HPAI. HPAI is still present in the wild bird population and the extent of possible future outbreaks, with heightened risk during the migration seasons, cannot be predicted. According to the U.S. Centers for Disease Control and Prevention, the human health risk to the U.S. public from HPAI viruses is considered to be low. Also, according to the USDA, HPAI cannot be transmitted through safely handled and properly cooked eggs. There is no known risk related to HPAI associated with eggs that are currently in the market and no eggs have been recalled.
The Company continues to work closely with federal, state and local government officials and focused industry groups to mitigate the risk of future outbreaks and effectively manage the response.
The APHIS division of the USDA and individual states track and publicly report individual incidents of HPAI by location. The Company will provide updated information in its next quarterly report to be filed with the Securities and Exchange Commission and does not expect to provide interim updates unless material.

Biotech

Cal-Maine Foods, Inc. Reports Positive Test Result For Avian Influenza At Texas Facility, Resulting In Depopulation Of ~1.6M Laying Hens And 337,000 Pullets, Or ~3.6% Of The Company's Total Flock As Of March 2, 2024

Cal-Maine Foods creates egg products joint venture with new investment

CPI read: Food at home prices were up less than 1% in August

Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Metcash Limited (MCSHF – Research Report) and Cal-Maine Foods...

Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Metcash Limited (OtherMCSHF) and Cal-Maine Foods (CALM)

Eggs, margins and Cal-Maine Foods' stock price

Nathan's Famous: Still Waiting For This Dog To Sizzle

Catalyst Watch: Tesla deliveries, Nike earnings, port strike threat and the jobs report

Wall Street Breakfast: The Week Ahead

Earnings week ahead: Nike, Carnival, Constellation Brands, and more

This week, several major companies will be reporting earnings. Among them are Nike (NKE), Carnival (CCL), Constellation Brands (STZ), Conagra Brand...

Options Volatility and Implied Earnings Moves This Week, September 30 – October 04, 2024

Comments

Cal-Maine Foods

Vendite allo scoperto

Cal-Maine Foods (NASDAQ:CALM) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO